Alembic Pharmaceuticals has appointed Manish Kejriwal as an Independent Director of the company for the period of five consecutive years effective from March 31, 2024. Kejriwal brings over 30 years of experience in private equity investments and is currently the founder and Managing Partner of Kedaara Capital.

Prior to founding Kedaara Capital, Kejriwal served as the head of the India office of Temasek Holdings, managing all investments and activities. He also held a prominent role as a Partner at McKinsey & Company, Inc., where he co-founded "The Private Equity Practice" and authored influential reports such as the "NASSCOM McKinsey reports."

Kejriwal currently serves on the boards of Bajaj Finserv, Bajaj Holdings Investment, various Kedaara investee companies, and K Raheja Corp Investment Managers.

An active member of the Young Presidents' Organization (YPO) and a Young Global Leader (YGL) recognised by the World Economic Forum, Kejriwal is deeply involved in education initiatives, including the United World College movement and Ashoka University. He has authored articles on private equity in India, featured in leading publications, and is a sought-after speaker at conferences worldwide.